It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
In this video, Prof. Niels van de Donk of VU University Medical Center, Amsterdam, briefly discusses the multiple mechanisms of action of DARZALEX® and how the drug promotes myeloma and immunosuppressor cell death, leading to durable anti-tumour responses
